Surgical Staging

In general, cancers are divided into categories or stages, with the assignment with a stage based on the risk for recurrence. For vulvar cancer the final stage depends on the pathologic review of the surgical specimens from the vulva and regional lymph nodes.

Stage IA: These lesions do not require a regional lymph node evaluation because of the low risk of metastasis.

Stage 1B: These tumors have deeper invasion (great than 1mm), but the regional lymph nodes are negative. These patients remain in Stage 1 category since they have a no risk for recurrence.

Stage II: The tumors have a local extension to the urethra, anus or vagina with negative lymph nodes. These patients have a lower risk of recurrence than patients described as Stage III.

Stage III: This stage includes patients with lymph node metastases regardless of size, location or extension of the primary vulvar tumor. The presence and extent of lymph node involvement is the single most important factor in the determining the risk of recurrence.

Spotlight

Check out this Women Magazine/aWomensheath.com page on gynecologic cancers, featuring our Listen, Learn, Act message and an article by National Race Surgeons Team Captain Linda Duska, M.D.

Awareness

This year’s GCAM awareness is focused on the important link between obesity and endometrial cancer. Check out the new toolkit to learn more.

Research

Prize applications are due on October 8, 2014. The Foundation for Women’s Cancer is pleased to share its 2014-2015 Research Grants and Awards booklet.

Education

The next Gynecologic Cancer Survivors Course will be Saturday, Oct. 11, 2014 in West Bloomfield, MI. For more information on educational events and courses, click here.